Difficulty: Medium
Average Score: 88%
Practice
Which of the following drugs is most likely to cause additive anemia and neutropenia if administered to an AIDS patient taking zidovudine?
Correct answer
C
Rationale
The correct answer is C) Ganciclovir. Ganciclovir is an antiviral medication that can cause additive bone marrow suppression when used concomitantly with zidovudine, leading to increased risk of anemia and neutropenia. This is due to the synergistic myelosuppressive effects of both drugs when used together, making this combination particularly risky for patients, such as AIDS patients, who are already immunocompromised.
Option A) Acyclovir is an antiviral medication used to treat herpes infections and does not have a significant interaction with zidovudine leading to additive anemia and neutropenia.
Option B) Amantadine is an antiviral medication primarily used to treat influenza A and Parkinson's disease, and it does not have a known significant interaction with zidovudine causing additive anemia and neutropenia.
Option D) Pentamidine is an antimicrobial agent used to prevent and treat Pneumocystis jiroveci pneumonia in patients with HIV/AIDS, but it does not typically cause additive anemia and neutropenia when used with zidovudine.
Understanding potential drug interactions is crucial in the management of patients, especially those with complex medical conditions like AIDS. Nurses and healthcare providers need to be aware of these interactions to prevent adverse effects and ensure patient safety when administering multiple medications concurrently.
Option A) Acyclovir is an antiviral medication used to treat herpes infections and does not have a significant interaction with zidovudine leading to additive anemia and neutropenia.
Option B) Amantadine is an antiviral medication primarily used to treat influenza A and Parkinson's disease, and it does not have a known significant interaction with zidovudine causing additive anemia and neutropenia.
Option D) Pentamidine is an antimicrobial agent used to prevent and treat Pneumocystis jiroveci pneumonia in patients with HIV/AIDS, but it does not typically cause additive anemia and neutropenia when used with zidovudine.
Understanding potential drug interactions is crucial in the management of patients, especially those with complex medical conditions like AIDS. Nurses and healthcare providers need to be aware of these interactions to prevent adverse effects and ensure patient safety when administering multiple medications concurrently.